Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
3.34M
-
Shares change
-
+974K
-
Total reported value, excl. options
-
$32.7M
-
Value change
-
+$9.2M
-
Number of buys
-
14
-
Number of sells
-
-5
-
Price
-
$9.80
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q1 2015
20 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q1 2015.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.34M shares
of 237M outstanding shares and own 1.41% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (987K shares), Broadfin Capital, LLC (964K shares), FMR LLC (423K shares), FRANKLIN RESOURCES INC (357K shares), PointState Capital LP (203K shares), J. Goldman & Co LP (121K shares), Telemetry Investments, L.L.C. (77.3K shares), Weiss Multi-Strategy Advisers LLC (53.1K shares), Alyeska Investment Group, L.P. (50K shares), and UBS OCONNOR LLC (41K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.